ClinicalTrials.Veeva

Menu

Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

N

Naval Medical Center

Status

Active, not recruiting

Conditions

Cardiac Death, Sudden
Cardiac Death
Wolf Parkinson White Syndrome

Treatments

Procedure: Standard of care without ablation
Procedure: Ablation

Study type

Observational

Funder types

Other U.S. Federal agency

Identifiers

NCT06798961
NMCSD.2024.0019

Details and patient eligibility

About

The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.

Full description

The LEAD-AP study is a dual arm retrospective observational cohort study (using existing records) to investigate the long-term outcomes of patients diagnosed with an accessory pathway during their military service.

Overall objective: Identifying additional risk factors associated with sudden cardiac death to help with risk stratification and guide ablation criteria for patients diagnosed with accessory pathways between the ages of 18-40.

Specific Aim/Research Question: The investigators will evaluate whether patients with an ablation have improved outcomes.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Active Duty between ages 18-40 who were diagnosed with an accessory pathway between 1/1/1990 - 5/30/2024.

Exclusion criteria

  • Patient without the diagnosis of Wolf Parkinson's White (WPW) syndrome

Trial design

1,000 participants in 1 patient group

All patients
Description:
Patients diagnosed with Accessory pathway between ages 18-40.
Treatment:
Procedure: Ablation
Procedure: Standard of care without ablation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems